[Osteopontin in rheumatoid arthritis].
Saeki
Yukihiko
Y
Department of Clinical Research, NHO Osaka-Minami Medical Center.
D000818:Animals; D001172:Arthritis, Rheumatoid / Q000209:etiology*; D001862:Bone Resorption / Q000235:genetics; D002352:Carrier Proteins / Q000502:physiology; D002454:Cell Differentiation / Q000235:genetics; D006801:Humans; D016023:Integrins / Q000502:physiology; D008562:Membrane Glycoproteins / Q000502:physiology; D010010:Osteoclasts / Q000166:cytology / Q000502:physiology; D053495:Osteopontin; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; D012795:Sialoglycoproteins / Q000502:physiology*; D018417:Th1 Cells / Q000276:immunology
D002352:Carrier Proteins; D016023:Integrins; D008562:Membrane Glycoproteins; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; C506895:SPP1 protein, human; D012795:Sialoglycoproteins; C505686:TNFRSF11A protein, human; C505688:TNFSF11 protein, human; D053495:Osteopontin